Fact CheckerSign in

NCT06948110Recruiting

Deciphering the Genetic Architecture of Autoimmune Diseases

Source: ClinicalTrials.gov · Last updated 4 Nov 2026

Brief summary (registry, in English)

Background: Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause these diseases have been well studied in people with European and Asian ancestors. But some diseases behave differently in people who are native to North and South America. Researchers want to know more about the gene changes and other factors that may cause autoimmune diseases among these people. This project will be based in Peru. Objective: To study how gene changes can lead to autoimmune diseases in people native to Peru. Eligibility: People aged 18 years and older with an autoimmune disease. These may include systemic lupus erythematosus; Sjogren disease; scleroderma; rheumatoid arthritis; seronegative spondylo-arthropathies; and systemic vasculitis. Family members and healthy volunteers are also needed. Design: Participants will have 2 clinic visits; these will be 2 weeks apart. The clinics will be in Lima, Iquitos, and other sites in Peru. Visit 1: Participants will have a physical exam. They will answer questions about their health risks and habits. They will provide blood and urine samples. Visit 2: Participants will provide a second blood sample and a stool sample. They will talk about the results of their first clinical exam with researchers. The cost of travel to and from the clinics will be provided. Participants will get $30 per visit and a snack.

Status (registry)
Recruiting
Study type
Observational
Enrollment
300 (estimated)
First submitted
25 Apr 2025
Start date
9 Nov 2026
Primary completion date
22 Apr 2030
Lead sponsor
National Human Genome Research Institute (NHGRI)
Diseases
Lupus (SLE)
NCT number
NCT06948110

What you commit to

  • Study type: Observational
  • Planned participants: 300
  • From 9 Nov 2026 to the primary completion date, 22 Apr 2030
  • 2 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • -People diagnosed with a chronic viral disease: HIV, hepatitis C or HTLV-1.

Criteria the registry did not label

  • INCLUSION CRITERIA:
    • Any person who meets the criteria for inclusion in the study will be considered and must have the patient's signed informed consent for participation.
    • Autoimmune Disease Diagnosis:
    • Cases:
  • Patients diagnosed with SLE, Sjogren's disease, scleroderma, rheumatoid arthritis, seronegative spondyloarthropathies, and systemic vasculitis, as defined by the American College of Rheumatology classification criteria.
  • Over 18 years old
    • Controls:
  • Family members of identified cases, and unrelated individuals. The controls would be from the same community as the patients and families studied, and of the same age and gender. Screening for autoimmune diseases and allergic diseases will be performed.
  • Over 18 years old

Age in the registry: 18 years to 115 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Amazon Rainforest
Coordinator of this site? Confirm its status
LimaPeruRecruiting
National Human Genome Research Institute (NHGRI)
Coordinator of this site? Confirm its status
BethesdaUnited StatesCompleted

This page is information, not medical advice. Discuss any trial with your doctor.